Table 4 Prescribed SGLT2 and GLP-1 medications for patients with diabetes mellitus and cardiovascular risk

Dapagliflozin

21

19.2

Dulaglutide

11

23.4

Dapaglifloxin 5 mg/ metformin 500 mg

2

18

Insulin degludec

2

4.3

Empagliflozin

83

76.1

Insulin degludec

5

10.6

Empagliflozin/metformin n HCL 12.5/1000 mg

3

2.8

Insulin glargine

4

8.5

–

–

–

Liragluide (Victoza)

16

34.04

–

–

–

Lixisenatide

5

10.6

–

–

–

Tresiba

4

8.5